Zimmer Biomet Holdings (ZBH) Free Cash Flow (2009 - 2026)

Zimmer Biomet Holdings has reported Free Cash Flow for 18 years, with the latest figure at $393.6 million in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 19.96% year-over-year to $393.6 million in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 3.44% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, up 13.66% from the prior year.
• Free Cash Flow was $393.6 million for Q2 2026 at Zimmer Biomet Holdings, up from $323.1 million in the prior quarter.
• The five-year high for Free Cash Flow was $525.6 million in Q4 2023, with the low at $172.9 million in Q1 2024.
• Average Free Cash Flow over 5 years is $330.2 million, with a median of $325.6 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow tumbled 37.31% in 2022, then jumped 190.71% in 2023.
• Over 5 years, Free Cash Flow stood at $180.8 million in 2022, then soared by 190.71% to $525.6 million in 2023, then retreated by 13.47% to $454.8 million in 2024, then retreated by 2.68% to $442.6 million in 2025, then retreated by 11.07% to $393.6 million in 2026.
• The last three Free Cash Flow figures came in at $393.6 million (Q2 2026), $323.1 million (Q1 2026), and $442.6 million (Q4 2025), per Business Quant data.